TTHX1114(NM141) in Combination With DWEK/DSO

Clinical trial NCT04676737 · COMPLETED

Trial details

NCT number: NCT04676737
Sponsor: Trefoil Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fuchs' Endothelial Dystrophy Fuchs Dystrophy Fuchs

Start date: 2021-02-01
Primary completion: 2022-11-16
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.